Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003148640 | SCV003836582 | benign | Familial adenomatous polyposis 1 | 2023-02-19 | reviewed by expert panel | curation | The c.1458T>C (p.Tyr486=) variant in APC is a synonymous (silent) variant that is not predicted to impact splicing (BP4, BP7). The highest population minor allele frequency (non-cancer) in gnomAD v2.1.1 is 69.75% in Latino/Admixed American population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold (0.1%) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BA1, BP4, BP7 (VCEP specifications Version 1.0, date of approval: 12/12/2022). |
Eurofins Ntd Llc |
RCV000035064 | SCV000109810 | benign | not specified | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000131423 | SCV000186404 | benign | Hereditary cancer-predisposing syndrome | 2014-10-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000035064 | SCV000301587 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000275522 | SCV000451988 | benign | APC-Associated Polyposis Disorders | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV001675589 | SCV000602510 | benign | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003148640 | SCV000647179 | benign | Familial adenomatous polyposis 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000131423 | SCV000681463 | benign | Hereditary cancer-predisposing syndrome | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000755636 | SCV000883033 | benign | Desmoid disease, hereditary; Carcinoma of colon; Familial adenomatous polyposis 1; Neoplasm of stomach; Hepatocellular carcinoma | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001675589 | SCV001894230 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30272267) |
Pathology and Clinical Laboratory Medicine, |
RCV000035064 | SCV002073833 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Sema4, |
RCV000131423 | SCV002535674 | benign | Hereditary cancer-predisposing syndrome | 2019-12-09 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV003148640 | SCV004017494 | benign | Familial adenomatous polyposis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000035064 | SCV000058704 | benign | not specified | 2008-03-01 | no assertion criteria provided | clinical testing | |
Systems Biology Platform Zhejiang California International Nano |
RCV000074147 | SCV000105740 | cancer | Familial colorectal cancer | no assertion criteria provided | not provided | Converted during submission to other. | |
Mayo Clinic Laboratories, |
RCV000035064 | SCV000256922 | benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353619 | SCV000591074 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The c.1458T>C, p.Tyr486Tyr silent variant, located in exon 12 of APC, is not expected to have clinical significance because it does not alter an amino acid residue, is not located near a splice junction, is listed in dbSNP (rs_id:rs2229992) with a minor allele frequency of 0.46. Based on the above information, this is a likely benign variant. | |
Diagnostic Laboratory, |
RCV000035064 | SCV001744287 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000035064 | SCV001918098 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000035064 | SCV001957590 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000035064 | SCV001970515 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000035064 | SCV001977893 | benign | not specified | no assertion criteria provided | clinical testing | ||
Institute for Biomarker Research, |
RCV000131423 | SCV002050299 | benign | Hereditary cancer-predisposing syndrome | 2021-12-21 | no assertion criteria provided | clinical testing |